Desk›Healthcare› Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd
BSE 544350 · NSE AGARWALEYE · ISIN INE943P01029 · Group A · Active
Healthcare › Healthcare › Healthcare Services › Hospital
₹507.70
+2.21%
BSE close, 28 August 2026
₹16,095.42 cr
31.7 cr shares · Small cap
₹3,938.79 cr
as published
350.1× · —
EPS ₹1.45 · BV —
1,293.39 / 39.45
₹ cr, as filed
27
7 selected · 26%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -10.6% |
|---|---|
| Against 52-week low | +26.3% |
| Day change | +2.21% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹1.45 |
|---|---|
| Price / earnings | 350.14× |
| Price / book | — |
| Book value — derived, price ÷ P/B | — |
| Return on equity | — |
| Operating margin | 25.87% |
| Net margin | 4.36% |
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 382.62 | 16.67 | 0.53 | 25.87% | 4.36% |
| Mar-26 · Q | 347.86 | 10.60 | 0.33 | 26.78% | 3.05% |
| FY25-26 | 1,293.39 | 39.45 | 1.25 | 25.80% | 3.05% |
Quarter on quarter
- Revenue, quarter on quarter
- +10.0%
- Net profit, quarter on quarter
- +57.3%
- Operating margin, quarter on quarter
- -91 bps
Disclosure profile 27 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| KMP | 1 |
| Press Release | 1 |
| Results | 1 |
| Scheme of Arrangement | 1 |
| Selected sub-total | 7 |
| Procedural | |
| SAST | 7 |
| AGM / EGM | 3 |
| Analyst / Investor Meet | 3 |
| Annual Report | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Monitoring Agency | 1 |
| Newspaper Publication | 1 |
| Subsidiary Incorporation | 1 |
| Trading Window | 1 |
| Procedural sub-total | 20 |
| Total | 27 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
27 filings · 7 selected · busiest 2026-08-14
Filing rhythm · the twelve most recent
2026-08-252026-10-07
SelectedProcedural
Filings
27 in the window · 9 earlier on record
-
7 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026, is enclosed.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
5 October 2026 ·
Scheme of Arrangement
Receipt of sanction from the Honble NCLT, Chennai Bench towards the scheme of amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited and their respective ....
Company Update / Scheme of Arrangement View filing →
-
29 September 2026 ·
Updates on Acquisition
Update on Step-down wholly owned subsidiary in Nigeria by Orbit Healthcare Services (Mauritius) Limited, a direct wholly owned subsidiary of the Company.
Company Update / Acquisition View filing →
-
29 September 2026 ·
Cessation
Completion of Second Term of 5 (Five) Consecutive Years by Mr. Sanjay Anand (DIN: 02501139), Independent Director of the Company
Company Update / Cessation View filing →
-
28 September 2026 ·
Closure of Trading Window
Closure of Trading Window pursuant to Dr. Agarwals Health Care Limited - Code of Conduct for Prevention of Insider Trading
Insider Trading / SAST / Closure of Trading Window View filing →
-
21 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting Results and the Consolidated Scrutinizer's Report of the 16th AGM of the Company, is submitted.
AGM/EGM / AGM View filing →
-
21 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 16th Annual General Meeting of Dr. Agarwal's Health Care Limited held on Monday, September 21, 2026, is submitted.
AGM/EGM / AGM View filing →
-
28 August 2026 ·
Reg. 34 (1) Annual Report.
Annual Report of the Company for the Financial Year 2025-26, is submitted.
Others / Reg. 34 (1) Annual Report View filing →
-
28 August 2026 ·
Sixteenth Annual General Meeting Of Dr Agarwals Health Care Limited To Be Held On September 21, 2026
Notice convening the Sixteenth AGM of the Company on September 21, 2026, along with the Annual Report for the financial year 2025-26, is submitted.
AGM/EGM / AGM View filing →
-
27 August 2026 ·
Press Release / Media Release
Media Release - Launch of World's First Pinhole Pupilloplasty (PPP) Centre by Dr. Agarwals Eye Hospital Limited, a subsidiary of the Company, is submitted
Company Update / Press Release / Media Release View filing →
-
25 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Investors Meet is submitted.
Company Update / Analyst / Investor Meet View filing →
-
25 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DB International Trust (Singapore) Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Claymore Investments (Mauritius) Pte Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hyperion Investments Pte Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Invesco Mutual Fund
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
7 August 2026 ·
Earnings Call Transcript
Transcript of the discussion held on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30, 2026, at the analyst call held on August 04, ....
Company Update / Earnings Call Transcript View filing →
-
4 August 2026 ·
Analyst / Investor Meet - Outcome
Link for the Audio recording of the Analyst / Earnings Conference call held on the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended June 30, ....
Company Update / Analyst / Investor Meet View filing →
-
4 August 2026 ·
Monitoring Agency Report
Dr. Agarwal's Health Care Limited - Monitoring Agency Report for the quarter ended June 30, 2026, is submitted.
Company Update / Monitoring Agency Report View filing →
-
4 August 2026 ·
Investor Presentation
Presentation on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30, 2026, is attached.
Company Update / Investor Presentation View filing →
-
4 August 2026 ·
Consolidated And Standalone Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026.
Consolidated and Standalone Unaudited Financial Results of the Company for the quarter ended June 30, 2026 is submitted.
Result / Financial Results View filing →
-
4 August 2026 ·
Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter Ended June 30, 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Outcome of the Meeting of the Board of Directors of the Company held on August 04, 2026, is attached.
Board Meeting / Outcome of Board Meeting View filing →
-
28 July 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Analyst / Earnings Conference call to discuss the Unaudited Financial Results (Standalone & Consolidated) of the Company For The Quarter Ended June 30, 2026, is attached
Company Update / Analyst / Investor Meet View filing →
-
28 July 2026 ·
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026
Dr. Agarwals Health Care Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Board Meeting / Board Meeting View filing →
-
20 July 2026 ·
Newspaper Publication
Newspaper Advertisement of Notice of Hearing of the Company's Petition in relation to the Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care ....
Company Update / Newspaper Publication View filing →
RSS feed for Dr. Agarwals Health Care Ltd · the 50 most recent filings